COVID-19

September 24, 2021

National Academies’ Forum on Microbial Threats

National Academies’ Forum on Microbial Threats https://www.thearcadygroup.com/wp-content/uploads/2021/09/Arcady-post.png 610 557 The Arcady Group The Arcady Group https://www.thearcadygroup.com/wp-content/uploads/2021/09/Arcady-post.png September 24, 2021 September 24, 2021

January 28, 2021

M4ALL Announces New Synthesis for Molnupiravir for COVID-19

M4ALL Announces New Synthesis for Molnupiravir for COVID-19 https://www.thearcadygroup.com/wp-content/uploads/2021/01/science-in-hd-OdEB1LNUidc-unsplash-scaled.jpg 2560 1707 The Arcady Group The Arcady Group https://www.thearcadygroup.com/wp-content/uploads/2021/01/science-in-hd-OdEB1LNUidc-unsplash-scaled.jpg January 28, 2021 January 25, 2021

April 3, 2020

Stop TB Partnership Launches Virtual Innovation Spotlights

Stop TB Partnership Launches Virtual Innovation Spotlights https://www.thearcadygroup.com/wp-content/uploads/2020/04/STBP_ReimaginingTBCare_Qure_Apr20-pdf.jpg 1497 1058 The Arcady Group The Arcady Group https://www.thearcadygroup.com/wp-content/uploads/2020/04/STBP_ReimaginingTBCare_Qure_Apr20-pdf.jpg April 3, 2020 September 9, 2020

National Academies’ Forum on Microbial Threats

M4ALL Announces New Synthesis for Molnupiravir for COVID-19

Stop TB Partnership Launches Virtual Innovation Spotlights

Accelerating the availability and uptake
of life-saving technologies and medications for patients who need them most.

Navigation

Latest Resources

Stay Connected

COVID-19

National Academies’ Forum on Microbial Threats

M4ALL Announces New Synthesis for Molnupiravir for COVID-19

Stop TB Partnership Launches Virtual Innovation Spotlights

Accelerating the availability and uptake of life-saving technologies and medications for patients who need them most.

Accelerating the availability and uptake
of life-saving technologies and medications for patients who need them most.